Understand how the extension of the deadline for the pilot project for regulatory evaluation of innovative medical devices impacts the healthcare sector and how QR Group can help.

Anvisa has extended the deadline for submitting Innovative Medical Devices projects in the pilot project for regulatory evaluation, now with a deadline until January 19, 2024. This project aims to facilitate the entry of innovative technologies into the Brazilian healthcare sector. QR Group, an ANVISA regulatory specialist, is ready to help international manufacturers submit their innovations within this deadline, ensuring regulatory compliance and efficiency in the process.

Impacts of the Extension on the Innovative Medical Device Sector

The extension of the deadline for submitting projects until January 19, 2024 allows more companies, both national and international, to participate in Anvisa’s pilot project. This provides a larger window for the submission of innovative proposals, essential to improve the supply of medical devices in Brazil. QR Group, with its extensive experience in the ANVISA regulatory process, can guide your company from submission to approval, avoiding setbacks that could delay the entry of your products into the market.

How Can QR Group Help Manufacturers of Innovative Medical Devices?

With QR Group’s support, international manufacturers can participate in this pilot project in an agile and effective manner. Acting as a Brazilian Registration Holder (BRH), QR Group ensures that its products meet ANVISA’s requirements, facilitating the regulatory process and accelerating the introduction of new technologies in Brazil. QR Group eliminates conflicts of interest and ensures a transparent and efficient process, focused on the safety and efficacy of medical devices.

Opportunity

Anvisa’s extension of the deadline reinforces the importance of innovative medical devices for the Brazilian healthcare system. This initiative encourages companies to submit proposals that meet the demands of the healthcare market with technological solutions that increase the efficiency and quality of healthcare services. QR Group is prepared to assist in complying with the requirements of the Call for Proposals No. 11 and help your company submit safe and effective devices for regulatory evaluation.

If your company would like to participate in Anvisa’s pilot project for innovative medical devices, contact QR Group. Our team of experts is ready to ensure that your products meet all regulatory requirements and are introduced to the market quickly and efficiently.

Glossary:

• Brazilian Registration Holder (BRH): Responsible for the registration of medical devices in Brazil, ensuring regulatory compliance with ANVISA.
• Call for Proposals: Official document that defines the rules for participation in a project or regulatory process.
• ANVISA: National Health Surveillance Agency, responsible for the regulation of health products in Brazil.

See more details on how QR Group can assist in the registration of medical devices in Brazil and check the source at ANVISA.